Live stream preview
Anti-sclerostin antibody treatment prevents myeloma induced bone disease and increases bone strength Michelle Mc Donald
ANZ Bone & Mineral Society
•
21m
Up Next in ANZ Bone & Mineral Society
-
OA Mutations in MAP3K7 and TAB2 cause...
-
Fracture associated mortality fractur...
-
Deterioration in bone microstructure ...